Patents by Inventor Fred M. Tatum

Fred M. Tatum has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6573093
    Abstract: Mutants of P. haemolytica provide excellent safety and efficacy when used as vaccines in ruminants, for example cattle, sheep, and goats, subject to pneumonic pasteurellosis. They can be administered by a variety of routes. Especially preferred is the use in animal feeds. The mutants are not reverting and contain no foreign DNA and no introduced antibiotic resistance genes.
    Type: Grant
    Filed: October 19, 2001
    Date of Patent: June 3, 2003
    Assignee: Biotechnology Research and Development Corporation
    Inventors: Robert E. Briggs, Fred M. Tatum
  • Patent number: 6495145
    Abstract: Mutants of P. haemolytica provide excellent safety and efficacy when used as vaccines in ruminants, for example cattle, sheep, and goats, subject to pneumonic pasteurellosis. They can be administered by a variety of routes. Especially preferred is the use in animal feeds. The mutants are not reverting and contain no foreign DNA and no introduced antibiotic resistance genes.
    Type: Grant
    Filed: October 19, 2001
    Date of Patent: December 17, 2002
    Assignees: The United States of America as represented by the Secretary of Agriculture, Biotechnology Research and Development Corporation
    Inventors: Robert E. Briggs, Fred M. Tatum
  • Publication number: 20020150584
    Abstract: Mutants of P. haemolytica provide excellent safety and efficacy when used as vaccines in ruminants, for example cattle, sheep, and goats, subject to pneumonic pasteurellosis. They can be administered by a variety of routes. Especially preferred is the use in animal feeds. The mutants are not reverting and contain no foreign DNA and no introduced antibiotic resistance genes.
    Type: Application
    Filed: January 25, 2002
    Publication date: October 17, 2002
    Applicant: Biotechnology Research and Development Corporation
    Inventors: Robert E. Briggs, Fred M. Tatum
  • Publication number: 20020086413
    Abstract: Mutants of P. haemolytica provide excellent safety and efficacy when used as vaccines in ruminants, for example cattle, sheep, and goats, subject to pneumonic pasteurellosis. They can be administered by a variety of routes. Especially preferred is the use in animal feeds. The mutants are not reverting and contain no foreign DNA and no introduced antibiotic resistance genes.
    Type: Application
    Filed: October 19, 2001
    Publication date: July 4, 2002
    Inventors: Robert E. Briggs, Fred M. Tatum
  • Publication number: 20020039589
    Abstract: Mutants of P. haemolytica provide excellent safety and efficacy when used as vaccines in ruminants, for example cattle, sheep, and goats, subject to pneumonic pasteurellosis. They can be administered by a variety of routes. Especially preferred is the use in animal feeds. The mutants are not reverting and contain no foreign DNA and no introduced antibiotic resistance genes.
    Type: Application
    Filed: October 19, 2001
    Publication date: April 4, 2002
    Inventors: Robert E. Briggs, Fred M. Tatum
  • Patent number: 6331303
    Abstract: Mutants of P. haemolytica provide excellent safety and efficacy when used as vaccines in ruminants, for example cattle, sheep, and goats, subject to pneumonic pasteurellosis. They can be administered by a variety of routes. Especially preferred is the use in animal feeds. The mutants are not reverting and contain no foreign DNA and no introduced antibiotic resistance genes.
    Type: Grant
    Filed: September 25, 1998
    Date of Patent: December 18, 2001
    Assignee: Biotechnology Research and Development Corporation
    Inventors: Robert E. Briggs, Fred M. Tatum
  • Publication number: 20010018055
    Abstract: Virulence factor mutants of Pasteurellaceae provide excellent safety and efficacy when used as vaccines in mammals, especially ruminants, for example cattle, sheep, and goats, subject to pneumonic pasteurellosis. They can be administered by a variety of routes. Especially preferred is the use in animal feeds. The mutants are not reverting and contain no foreign DNA and no introduced antibiotic resistance genes.
    Type: Application
    Filed: December 15, 2000
    Publication date: August 30, 2001
    Inventors: Robert E. Briggs, Fred M. Tatum
  • Patent number: 5849305
    Abstract: Methylation of DNA can be a critical step in the introduction of DNA into P. haemolytica. A methyltransferase has been isolated and molecularly cloned for this purpose. Use of the methyltransferase has allowed construction of defined, attenuated mutants for use as vaccines to protect cattle.
    Type: Grant
    Filed: May 8, 1996
    Date of Patent: December 15, 1998
    Assignees: The United States of America as represented by the Secretary of the Department of Agriculture, Biotechnology Research and Development Corporation
    Inventors: Robert E. Briggs, Fred M. Tatum
  • Patent number: 5840556
    Abstract: Tools for genetically engineering Pasteurellaceae are provided. Replication-conditional plasmids which are useful for the Pasteurellaceae have been isolated and characterized. The plasmids can be utilized for delivery of DNA segments into the Pasteurellaceae in situations where control of extrachromosomal replication desired, such as in achieving allelic exchange or site-directed mutagenesis.A restriction endonuclease, HsoI, was isolated from a bovine lung isolate of Haemophilus somnus. The enzyme was found to be a true isoschizomer of HinPI, a commercially available enzyme originally isolated from Haemophilus influenzae PI. Commercially available HhaI methyl transferase was found to protect against cleavage by both enzymes. Methylation of foreign plasmid DNA was found to enhance transformation of Haemophilus somnus in excess of four orders of magnitude.
    Type: Grant
    Filed: December 19, 1996
    Date of Patent: November 24, 1998
    Assignees: The United States of America as represented by the Department of Agriculture, Biotechnology Research and Development Corporation
    Inventors: Robert E. Briggs, Fred M. Tatum
  • Patent number: 5824525
    Abstract: Methylation of DNA can be a critical step in the introduction of DNA into P. haemolytica. A methyltransferase has been isolated and molecularly cloned for this purpose. Use of the methyltransferase has allowed construction of defined, attenuated mutants for use as vaccines to protect cattle.
    Type: Grant
    Filed: May 8, 1996
    Date of Patent: October 20, 1998
    Assignees: Biotechnology Research and Development Corporation, The United States of America as represented by the Department of Agriculture
    Inventors: Robert E. Briggs, Fred M. Tatum
  • Patent number: 5733780
    Abstract: Methylation of DNA can be a critical step in the introduction of DNA into P. haemolytica. A methyltransferase has been isolated and molecularly cloned for this purpose. Use of the methyltransferase has allowed construction of defined, attenuated mutants for use as vaccines to protect cattle.
    Type: Grant
    Filed: May 8, 1996
    Date of Patent: March 31, 1998
    Assignees: The United States of America as represented by the Department of Agriculture, Biotechnology and Research and Development Corporation
    Inventors: Robert E. Briggs, Fred M. Tatum
  • Patent number: 5693777
    Abstract: Methylation of DNA can be a critical step in the introduction of DNA into P. haemolytica. A methyltransferase has been isolated and molecularly cloned for this purpose. Use of the methyltransferase has allowed construction of defined, attenuated mutants for use as vaccines to protect cattle.
    Type: Grant
    Filed: May 8, 1996
    Date of Patent: December 2, 1997
    Assignees: The United States of America as represented by the Secretary of Agriculture, Biotechnology Research and Development Corporation
    Inventors: Robert E. Briggs, Fred M. Tatum
  • Patent number: 5683900
    Abstract: Methylation of DNA can be a critical step in the introduction of DNA into P. haemolytica. A methyltransferase has been isolated and molecularly cloned for this purpose. Use of the methyltransferase has allowed construction of defined, attenuated mutants for use as vaccines to protect cattle.
    Type: Grant
    Filed: May 8, 1996
    Date of Patent: November 4, 1997
    Assignees: The United States of America as represented by the Department of Agriculture, Biotechnology Research and Development Corporation
    Inventors: Robert E. Briggs, Fred M. Tatum
  • Patent number: 5587305
    Abstract: Methylation of DNA can be a critical step in the introduction of DNA into P. haemolytica. A methyltransferase has been isolated and molecularly cloned for this purpose. Use of the methyltransferase has allowed construction of defined, attenuated mutants for use as vaccines to protect cattle.
    Type: Grant
    Filed: December 6, 1993
    Date of Patent: December 24, 1996
    Assignees: The United States of America as represented by the Department of Agriculture, Biotechnology Research and Development Corporation
    Inventors: Robert E. Briggs, Fred M. Tatum
  • Patent number: RE38028
    Abstract: Tools for genetically engineering Pasteurellaceae are provided. Replication-conditional plasmids which are useful for the Pasteurellaceae have been isolated and characterized. The plasmids can be utilized for delivery of DNA segments into the Pasteurellaceae in situations where control of extra-chromosomal replication desired, such as in achieving allelic exchange or site-directed mutagenesis. A restriction endonuclease, HsoI, was isolated from a bovine lung isolate of Haemophilus somnus. The enzyme was found to be a true isoschizomer of HinPI, a commercially available enzyme originally isolated from Haemophilus influenzae PI. Commercially available HhaI methyl transferase was found to protect against cleavage by both enzymes. Methylation of foreign plasmid DNA was found to enhance transformation of Haemophilus somnus in excess of four orders of magnitude.
    Type: Grant
    Filed: November 21, 2000
    Date of Patent: March 11, 2003
    Assignees: Biotechnology Research and Development Corporation, The United States of America as represented by the Department of Agriculture
    Inventors: Robert E. Briggs, Fred M. Tatum